These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 19459409)

  • 21. Oxadiazols: a new class of rationally designed anti-human immunodeficiency virus compounds targeting the nuclear localization signal of the viral matrix protein.
    Haffar O; Dubrovsky L; Lowe R; Berro R; Kashanchi F; Godden J; Vanpouille C; Bajorath J; Bukrinsky M
    J Virol; 2005 Oct; 79(20):13028-36. PubMed ID: 16189005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-20--a fusion drug, first of several to come.
    TreatmentUpdate; 1998 Dec; 10(10):2. PubMed ID: 11366015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthetic peptide analogs of intercellular adhesion molecule 1 (ICAM-1) inhibit HIV-1 replication in MT-2 cells.
    Fecondo JV; Pavuk NC; Silburn KA; Read DM; Mansell AS; Boyd AW; McPhee DA
    AIDS Res Hum Retroviruses; 1993 Aug; 9(8):733-40. PubMed ID: 8105834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravirion display of a peptide corresponding to the dimer structure of protease attenuates HIV-1 replication.
    Cartas M; Singh SP; Serio D; Rizvi TA; Kalyanaraman VS; Goldsmith CS; Zaki SR; Weber IT; Srinivasan A
    DNA Cell Biol; 2001 Dec; 20(12):797-805. PubMed ID: 11879573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HIV-1 assembly is initiated by p17 matrix protein].
    Vorkunova GK; Lupandin SI; Bukrinskaia AG
    Mol Biol (Mosk); 2011; 45(5):879-83. PubMed ID: 22393785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synonymous mutations in stem-loop III of Rev responsive elements enhance HIV-1 replication impaired by primary mutations for resistance to enfuvirtide.
    Ueno M; Kodama EN; Shimura K; Sakurai Y; Kajiwara K; Sakagami Y; Oishi S; Fujii N; Matsuoka M
    Antiviral Res; 2009 Apr; 82(1):67-72. PubMed ID: 19428597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of activity of the HIV-1 maturation inhibitor PA-457.
    Li F; Zoumplis D; Matallana C; Kilgore NR; Reddick M; Yunus AS; Adamson CS; Salzwedel K; Martin DE; Allaway GP; Freed EO; Wild CT
    Virology; 2006 Dec 5-20; 356(1-2):217-24. PubMed ID: 16930665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The N-Terminal T-T Motif of a Third-Generation HIV-1 Fusion Inhibitor Is Not Required for Binding Affinity and Antiviral Activity.
    Chong H; Qiu Z; Su Y; He Y
    J Med Chem; 2015 Aug; 58(16):6378-88. PubMed ID: 26256053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Random expression of human immunodeficiency virus-1 (HIV-1) p17 (epitopes) on the surface of the HIV-1-infected cell.
    Ota A; Liu X; Fujio H; Sakato N; Ueda S
    Hybridoma; 1998 Feb; 17(1):73-5. PubMed ID: 9523241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
    Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
    J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and in vitro enzymatic and antiviral evaluation of phosphoramidate d4T derivatives as chain terminators.
    Yang S; Pannecouque C; Lescrinier E; Giraut A; Herdewijn P
    Org Biomol Chem; 2012 Jan; 10(1):146-53. PubMed ID: 22069085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-20: a new class of drugs.
    STEP Perspect; 1999; 99(1):6. PubMed ID: 11367163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human immunodeficiency virus type 1 replication by nuclear chimeric anti-HIV ribozymes in a human T lymphoblastoid cell line.
    Michienzi A; Conti L; Varano B; Prislei S; Gessani S; Bozzoni I
    Hum Gene Ther; 1998 Mar; 9(5):621-8. PubMed ID: 9551610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 3-O-(3',3'-dimethylsuccinyl) derivative of betulinic acid (DSB) inhibits the assembly of virus-like particles in HIV-1 Gag precursor-expressing cells.
    DaFonseca S; Blommaert A; Coric P; Hong SS; Bouaziz S; Boulanger P
    Antivir Ther; 2007; 12(8):1185-203. PubMed ID: 18240859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of HIV-1 replication by a peptide dimerization inhibitor of HIV-1 protease.
    Davis DA; Brown CA; Singer KE; Wang V; Kaufman J; Stahl SJ; Wingfield P; Maeda K; Harada S; Yoshimura K; Kosalaraksa P; Mitsuya H; Yarchoan R
    Antiviral Res; 2006 Nov; 72(2):89-99. PubMed ID: 16687179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins.
    Huang M; Maynard A; Turpin JA; Graham L; Janini GM; Covell DG; Rice WG
    J Med Chem; 1998 Apr; 41(9):1371-81. PubMed ID: 9554870
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased anti-HIV-1 activity of CD4 CDR3-related synthetic peptides by scrambling and further structural modifications, including D-isomerization and dimerization.
    Kumagai K; Tokunaga K; Tsutsumi M; Ikuta K
    FEBS Lett; 1993 Sep; 330(2):117-21. PubMed ID: 7689978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel view of modelling interactions between synthetic and biological polymers via docking.
    Tsvetkov VB; Serbin AV
    J Comput Aided Mol Des; 2012 Dec; 26(12):1369-88. PubMed ID: 23239170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of novel antiviral agents on HIV-1 replication].
    Vorkunova GK; Kalnina LB; Burshteĭn ME; Serbin AV; Rodionov IL; Pavlova MV; Bukrinskaia AG
    Vopr Virusol; 2009; 54(2):27-31. PubMed ID: 19459409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [HIV-inhibiting activity of polyanion matrices and related substances containing adamantane and norbornene pharmacophores].
    Timofeev DI; Perminova NG; Serbin AV; Kiseleva IaIu; Nekliudov VV; Vatolin GIu; Kas'ian LI; Grebinik TS; Timofeev IV
    Antibiot Khimioter; 2003; 48(5):33-41. PubMed ID: 12968467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.